Saudi Arabia generic drugs market is expected to witness significant growth during the forecast period on account of growing prevalence of several chronic diseases such as cancer, diabetes, cardiovascular diseases, renal disorders, gastrointestinal disorders, among others in the country. Additionally, growing geriatric population which is susceptible to various diseases is expected to further increase the demand for generic drugs in the market through 2026. Furthermore, increasing count of drug patent expiration has made the room for entry and increase in demand for generic drugs in the market. Besides, several benefits associated with generic drugs such as their low cost, easy availability, composition like innovator drug, among others is expected to bolster the market growth over the next few years.

The Saudi Arabia generic drugs market can be segmented by type, mode of drug discovery, form, source, distribution channel, application, region and company. Based on application, the market can be categorized into cardiovascular diseases, diabetes, neurology, oncology, anti-inflammatory diseases, and others. The diabetes segment is expected to dominate the market on account of the growing prevalence of diabetes in the country. Saudi Arabia has second largest diabetic population in the Middle East region. The diabetes prevalence rate in Saudi Arabia among adults aged between 20-79 years reached to 15.8% in 2019. Additionally, cardiovascular disease is the leading cause of mortality worldwide, contributing to 31% of all deaths. Cardiovascular disease is also becoming a major health concern in the Gulf Council Countries, including Saudi Arabia, where it is estimated that CVD accounts for more than 45% of all deaths. In Saudi Arabia, lifestyle has changed dramatically because of rapid urbanization, with an increase in poor diet and the adoption of a sedentary lifestyle. As a result of this the prevalence of several chronic and lifestyle associated disease has significantly increased. This in turn will increase the demand for generic drugs significantly in the country.

The major companies operating in Saudi Arabia generic drugs market includes Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), Tabuk Pharmaceuticals Manufacturing Co., Jamjoom Pharmaceuticals Co., Riyadh Pharma, Al Jazeerah Pharmaceutical Industries Ltd (Hikma), Pfizer Saudi Company Ltd., Sanofi Aventis Arabia Co. Ltd., Novartis Saudi Arabia, GlaxoSmithKline Saudi Arabia Limited (GSK), Novo Nordisk Saudi Arabia, among others. Major players operating in the market are adopting strategies such as mergers & acquisitions, collaborations, product launches, among others in the market in order to stay competitive and having an edge over the other players operating in the market.

Years considered for this report:

Historical Years: 2016 – 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 – 2026

Objective of the Study:

  • To analyze the historical growth of the market size of Saudi Arabia generic drugs market from 2016 to 2019.
  • To estimate and forecast the market size of Saudi Arabia generic drugs market from 2020 to 2026 and growth rate until 2026. 
  • To classify and forecast Saudi Arabia generic drugs market based on type, mode of drug delivery, form, source, distribution channel, application, region and company.
  • To identify dominant region or segment in the Saudi Arabia generic drugs market.
  • To identify drivers and challenges for Saudi Arabia generic drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Saudi Arabia generic drugs market.
  • To identify and analyze the profile of leading players operating in Saudi Arabia generic drugs market.
  • To identify key sustainable strategies adopted by market players in Saudi Arabia generic drugs market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distributors across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of Saudi Arabia generic drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Generic Drugs manufacturers, end users, and other stakeholders
  • Distributers and suppliers of the products and other stakeholders
  • Organizations, forums, and alliances related to generic drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, Saudi Arabia generic drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Saudi Arabia Generic Drugs Market, By Type:

o   Small Molecule Generics

o   Biosimilars

  • Saudi Arabia Generic Drugs Market, By Mode of Drug Delivery:
    • Oral
    • Topical
    • Parenteral
    • Others
  • Saudi Arabia Generic Drugs Market, By Form:
    • Tablet
    • Capsule
    • Injection
    • Others
  • Saudi Arabia Generic Drugs Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • Saudi Arabia Generic Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Saudi Arabia Generic Drugs Market, By Application:
    • Cardiovascular Diseases
    • Diabetes
    • Neurology
    • Oncology
    • Anti-Inflammatory Diseases
    • Others
  • Saudi Arabia Generic Drugs Market, By Region:
    • Northern & Central
    • Southern
    • Eastern
    • Western

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Saudi Arabia generic drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Saudi Arabia Generic Drugs Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Saudi Arabia Generic Drugs Market

4.    Voice of Customer

5.    Executive Summary

6.    Saudi Arabia Generic Drugs Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Small Molecule Generics v/s Biosimilars)

6.2.2.     By Mode of Drug Delivery (Oral, Topical, Parenteral, Others)

6.2.3.     By Form (Tablet, Capsule, Injection, Others)

6.2.4.     By Source (In House v/s Contract Manufacturing Organizations)

6.2.5.     By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

6.2.6.     By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others)

6.2.7.     By Company (2020)

6.2.8.     By Region

6.3.  Product Market Map

7.    Saudi Arabia Small Molecule Generic Drugs Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Mode of Drug Delivery

7.2.2.     By Form

7.2.3.     By Source

7.2.4.     By Distribution Channel

7.2.5.     By Application

8.    Saudi Arabia Biosimilar Generic Drugs Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Mode of Drug Delivery

8.2.2.     By Form

8.2.3.     By Source

8.2.4.     By Distribution Channel

8.2.5.     By Application

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  Saudi Arabia Economic Profile

13.  Competitive Landscape

13.1.              Competition Outlook

13.2.              Company Profiles

13.2.1.  Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)

13.2.2.  Tabuk Pharmaceuticals Manufacturing Co.

13.2.3.  Jamjoom Pharmaceuticals Co.

13.2.4.  Riyadh Pharma

13.2.5.  Al Jazeerah Pharmaceutical Industries Ltd (Hikma)

13.2.6.  Pfizer Saudi Company Ltd.

13.2.7.  Sanofi Aventis Arabia Co. Ltd.

13.2.8.  Novartis Saudi Arabia

13.2.9.  GlaxoSmithKline Saudi Arabia Limited (GSK)

13.2.10.                Novo Nordisk Saudi Arabia

14.  Strategic Recommendations

15.  About Us & Disclaimer